Profibrotic Signaling and HCC Risk during Chronic Viral Hepatitis: Biomarker Development

Despite breakthroughs in antiviral therapies, chronic viral hepatitis B and C are still the major causes of liver fibrosis and hepatocellular carcinoma (HCC). Importantly, even in patients with controlled infection or viral cure, the cancer risk cannot be fully eliminated, highlighting a persisting...

Descripción completa

Detalles Bibliográficos
Autores principales: Virzì, Alessia, Gonzalez-Motos, Victor, Tripon, Simona, Baumert, Thomas F., Lupberger, Joachim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957739/
https://www.ncbi.nlm.nih.gov/pubmed/33801181
http://dx.doi.org/10.3390/jcm10050977

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957739/
https://www.ncbi.nlm.nih.gov/pubmed/33801181
http://dx.doi.org/10.3390/jcm10050977

Ejemplares similares